Risk charts of five-year mortality in COPD patients

A. Horner (Linz, Austria), P. Almagro (Barcelona, Spain), J. Soriano (Madrid, Spain), B. Kaiser (Linz, Austria), P. Martinez-Camblor (Hanover, NH, United States of America), D. Lang (Linz, Austria), I. Alfageme (Seville, Spain), C. Ciro (Tenerife, Spain), C. Esteban (Bizkaia, Spain), J. Soler-Cataluña (Valencia, Spain), J. De-Torres (Pamplona, Spain), M. Miravitlles (Barcelona, Spain), B. Celli (Boston, Massachusetts, United States of America), J. Marin (Zaragoza, Spain), M. Puhan (Zürich, Switzerland), P. Sobradillo (Vitoria, Spain), P. Lange (Copenhagen, Denmark), J. Garcia-Aymerich (Barcelona, Spain), A. Turner (Birmingham, United Kingdom), M. Han (Ann Arbor, MI, United States of America), A. Langhammer (Trondheim, Norway), P. Bakke (Bergen, Norway), A. Johannessen (Bergen, Norway), T. Oga (Kyoto, Japan), B. Cosío (Palma de Mallorca, Spain), J. Ancochea-Bermúdez (Madrid, Spain), A. Echazarreta (Buenos Aires, Argentina), N. Roche (Paris, France), P. Burgel (Paris, France), D. Sin (Vancouver, BC, Canada), A. Ramírez (Montreal, Qc, Canada), M. Studnicka (Salzburg, Austria), M. Flamm (Salzburg, Austria), B. Lamprecht (Linz, Austria)

Source: International Congress 2019 – COPD: epidemiology and spirometry
Session: COPD: epidemiology and spirometry
Session type: Poster Discussion
Number: 3322
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Horner (Linz, Austria), P. Almagro (Barcelona, Spain), J. Soriano (Madrid, Spain), B. Kaiser (Linz, Austria), P. Martinez-Camblor (Hanover, NH, United States of America), D. Lang (Linz, Austria), I. Alfageme (Seville, Spain), C. Ciro (Tenerife, Spain), C. Esteban (Bizkaia, Spain), J. Soler-Cataluña (Valencia, Spain), J. De-Torres (Pamplona, Spain), M. Miravitlles (Barcelona, Spain), B. Celli (Boston, Massachusetts, United States of America), J. Marin (Zaragoza, Spain), M. Puhan (Zürich, Switzerland), P. Sobradillo (Vitoria, Spain), P. Lange (Copenhagen, Denmark), J. Garcia-Aymerich (Barcelona, Spain), A. Turner (Birmingham, United Kingdom), M. Han (Ann Arbor, MI, United States of America), A. Langhammer (Trondheim, Norway), P. Bakke (Bergen, Norway), A. Johannessen (Bergen, Norway), T. Oga (Kyoto, Japan), B. Cosío (Palma de Mallorca, Spain), J. Ancochea-Bermúdez (Madrid, Spain), A. Echazarreta (Buenos Aires, Argentina), N. Roche (Paris, France), P. Burgel (Paris, France), D. Sin (Vancouver, BC, Canada), A. Ramírez (Montreal, Qc, Canada), M. Studnicka (Salzburg, Austria), M. Flamm (Salzburg, Austria), B. Lamprecht (Linz, Austria). Risk charts of five-year mortality in COPD patients. 3322

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predicting 12-month mortality in a Scottish COPD cohort
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009

Mortality of patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 631s
Year: 2007

Triglycerides are associated with five-year mortality in COPD patients
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012


Predictors of mortality in a well-characterised group of patients with COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012

10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018



Nutrition status and mortality rate during 5-years follow-up in patients with COPD.
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019

Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

30-days mortality in patients admitted with COPD
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Mortality risk in a Romanian cohort of patients hospitalised for COVID-19
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021


Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Relation between quality of life and morbidity and mortality in COPD patients: 7-year follow-up study
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011

Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Trends in COPD mortality – Tales from the Swedish mortality register
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

Risk factors for COPD mortality in women in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 463s
Year: 2006